12 Health Care Stocks Moving In Monday's Pre-Market Session

 

Gainers

  • Cerevel Therapeutics Hldg CERE stock increased by 18.0% to $39.49 during Monday's pre-market session. The market value of their outstanding shares is at $5.8 billion.
  • Eargo EAR stock increased by 17.88% to $1.45. The market value of their outstanding shares is at $57.0 million. The company's, Q2 earnings came out today.
  • Signify Health SGFY stock rose 15.7% to $22.99. The market value of their outstanding shares is at $4.0 billion. As per the news, the Q2 earnings report came out 3 days ago.
  • Quoin Pharmaceuticals QNRX shares moved upwards by 15.31% to $6.1. The market value of their outstanding shares is at $4.8 million.
  • Zai Lab ZLAB stock increased by 14.62% to $51.89. The company's market cap stands at $5.0 billion.
  • CinCor Pharma CINC stock moved upwards by 13.47% to $26.61. The market value of their outstanding shares is at $1.0 billion.

Losers

  • Reata Pharmaceuticals RETA shares fell 18.8% to $28.99 during Monday's pre-market session. The market value of their outstanding shares is at $1.0 billion. As per the news, the Q2 earnings report came out today.
  • Marker Therapeutics MRKR shares declined by 14.17% to $0.46. The company's market cap stands at $38.7 million.
  • Scholar Rock Holding SRRK shares decreased by 12.0% to $7.48. The company's market cap stands at $386.1 million.
  • Cognition Therapeutics CGTX stock declined by 11.83% to $2.76. The company's market cap stands at $62.3 million.
  • Aethlon Medical AEMD shares fell 10.18% to $1.5. The market value of their outstanding shares is at $24.9 million.
  • Athenex ATNX shares fell 9.69% to $0.86. The market value of their outstanding shares is at $104.8 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!